Collaboration Details

Print  Close

Title of Collaborative Activity:

Cancer and Women's Health Interagency Agreement

Description of Collaborative Activity:

This formal agreement establishes the framework and procedures to enhance collaborations and exchange of information between the Food and Drug Administration (FDA) Office of Women’s Health (OWH) and the National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities (CRCHD). Working together, FDA and NCI seek to increase scientific knowledge and understanding of cancer in women through targeted basic, clinical, bio-behavioral, translational, and community-based participatory research approaches/efforts. FDA and NCI both recognize the need for a unified approach to advancing scientific knowledge related to cancer and women’s health. This harmonized approach will aid in advancing the public health of all women through innovation in cancer research and medical therapies.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: